Jill Short in Louisa, Kentucky

Medical School: Sorry, her university is not listed
Graduation Year: 1998
The Primary Medical Specialty for Jill Short is listed as: Physician Assistant
Approximate Years of Experience: 26
PAC (PECOS ID)#: 7911021316
NPI #: 1619143146
NPI Created On: 05/05/2008
NPI Last Updated Listed as: 04/23/2010
Primary Taxonomy Code: 363AM0700X
License Number:
PA442
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Humana
• CareSource
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Automated urinalysis test
2. Blood test, clotting time
3. Coronavirus ag ia
4. Vaccine for influenza for administration into muscle, 0.5 ml dosage
5. Routine electrocardiogram (ekg) with tracing using at least 12 leads
6. Anti-clotting management for patient taking warfarin
7. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
8. Established patient office or other outpatient visit, typically 10 minutes
9. Established patient office or other outpatient visit, typically 15 minutes
10. Established patient office or other outpatient, visit typically 25 minutes
11. Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes
12. Chronic care management services at least 20 minutes per calendar month
13. Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge
14. Administration of influenza virus vaccine
15. Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment
16. Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
17. Annual depression screening, 15 minutes
18. Injection, methylprednisolone acetate, 80 mg
19. Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
20. Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)